» Articles » PMID: 22270966

MicroRNA-223 Functions As an Oncogene in Human Gastric Cancer by Targeting FBXW7/hCdc4

Overview
Specialty Oncology
Date 2012 Jan 25
PMID 22270966
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The aim of this study was (a) to determine the role of micro-223 (miR-223) in gastric cancer and (b) to elucidate its regulatory mechanism on the FBXW7/hCdc4 gene.

Materials And Methods: Artificial miR-223 and control oligonucleotide was transfected into gastric cancer cell line SGC7901 by using Lipofectamine2000. Apoptosis of miR-223 group and control group cells was analyzed by flow cytometry, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide and colony formation assays were performed to detect the cell viability, to survey migration of miR-223 group and control group cells; scratch wound-healing motility assays, Transwell Assay, and Western blot test were performed to measure the variance of hFBXW7. Luciferase Reporter Assay, which was done by pLUC-hFBXW7 WT-3'-UTR co-transfected with pLMP-hsa-miR-223 or pLMP plasmid (as control) into HEK293T cells, used to detect whether hFBXW7 is a direct target gene of miR-223. Gastric cancer cell line SGC7901 transfected with miR-223 or control oligonucleotide was resuspended in ECM gel and then was injected into the flank of nude mice, 4 weeks later, the nude mice were euthanized. The tumors were excised then were measured and weighted. SYBR-Green I-based real-time RT-PCR study was used to detect the level of miR-223 in 22 gastric cancer tissue and corresponding gastric mucosa tissues. Immunohistochemical method was applied to detect the protein of hFBXW7.

Results: Gastric cancer cell line SGC7901, transfected with miR-223, showed significant reduction in cellular apoptosis and increased proliferation and invasion in vitro. Similar results were found in tumorigenesis assays performed in nude mice. Moreover, 19 of 22 cancer tissue samples highly expressed miR-223, when compared with patient-matched normal gastric mucosa. Specifically, patients with lymph node metastasis or metastatic disease (M1) at an advanced pathological stage showed significantly higher expression of miR-223. FBXW7/hCdc4 protein (FBW7) levels in gastric cancer cases were inversely correlated with miR-223 expression. Overexpression of miR-223 in gastric cancer cell lines decreased FBW7 expression at the translational level and decreased FBXW7/hCdc4-driven luciferase-reporter activity.

Conclusion: In summary, the data indicated that miR-223 targets FBXW7/hCdc4 expression at the post-transcriptional level and appears to regulate cellular apoptosis, proliferation, and invasion in gastric cancer. MiR-223 may serve as a novel therapeutic target in gastric cancer.

Citing Articles

FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects.

Wang W, Liu X, Zhao L, Jiang K, Yu Z, Yang R Front Pharmacol. 2025; 15:1505027.

PMID: 39749199 PMC: 11694028. DOI: 10.3389/fphar.2024.1505027.


MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis.

Saadh M, Hussain Q, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B Biochem Genet. 2024; .

PMID: 39103713 DOI: 10.1007/s10528-024-10897-0.


Molecular insights and clinical implications for the tumor suppressor role of SCF E3 ubiquitin ligase.

Qi Y, Rezaeian A, Wang J, Huang D, Chen H, Inuzuka H Biochim Biophys Acta Rev Cancer. 2024; 1879(5):189140.

PMID: 38909632 PMC: 11390337. DOI: 10.1016/j.bbcan.2024.189140.


F-box proteins and gastric cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.

Yang Y, Xie Q, Hu C, Xu J, Chen L, Li Y Int J Med Sci. 2024; 21(8):1575-1588.

PMID: 38903918 PMC: 11186432. DOI: 10.7150/ijms.91584.


Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy.

Wang B, Zhu Y, Wang S, Li Z, Wang L, Rao W Gastric Cancer. 2023; 27(1):86-101.

PMID: 38019350 DOI: 10.1007/s10120-023-01446-6.


References
1.
Behm-Ansmant I, Rehwinkel J, Izaurralde E . MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol. 2007; 71:523-30. DOI: 10.1101/sqb.2006.71.013. View

2.
Guo C, Sah J, Beard L, Willson J, Markowitz S, Guda K . The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer. 2008; 47(11):939-46. PMC: 2739997. DOI: 10.1002/gcc.20596. View

3.
Calhoun E, Jones J, Ashfaq R, Adsay V, Baker S, Valentine V . BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. Am J Pathol. 2003; 163(4):1255-60. PMC: 1868306. DOI: 10.1016/S0002-9440(10)63485-2. View

4.
Nateri A, Riera-Sans L, Da Costa C, Behrens A . The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science. 2004; 303(5662):1374-8. DOI: 10.1126/science.1092880. View

5.
Miko E, Czimmerer Z, Csanky E, Boros G, Buslig J, Dezso B . Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res. 2009; 35(8):646-64. DOI: 10.3109/01902140902822312. View